Results 141 to 150 of about 417,668 (180)

12-month outcomes after voretigene neparvovec gene therapy in paediatric patients with RPE65-mediated inherited retinal dystrophy. [PDF]

open access: yesBr J Ophthalmol
Daruich A   +6 more
europepmc   +1 more source

Phenotypic variability of RP1-related inherited retinal dystrophy associated with the c.5797 C > T (p.Arg1933*) variant in the Japanese population. [PDF]

open access: yesSci Rep
Natsume K   +11 more
europepmc   +1 more source

Nanopore Deep Sequencing as a Tool to Characterize and Quantify Aberrant Splicing Caused by Variants in Inherited Retinal Dystrophy Genes. [PDF]

open access: yesInt J Mol Sci
Maggi J   +7 more
europepmc   +1 more source

Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice. [PDF]

open access: yesEye (Lond)
Testa F   +10 more
europepmc   +1 more source

The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene. [PDF]

open access: yesAm J Ophthalmol, 2019
Chung DC   +21 more
europepmc   +1 more source

Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy. [PDF]

open access: yesCell Death Dis, 2018
Noailles A   +4 more
europepmc   +1 more source

Deep Learning for Diagnosis of Choroideremia and <i>USH2A</i>-Associated Rod-Cone Dystrophy Using Macular OCT Volumes. [PDF]

open access: yesOphthalmol Sci
Mairot K   +9 more
europepmc   +1 more source

EDSpliCE, a CRISPR-Cas9 gene editing platform to rescue splicing, effectively corrects inherited retinal dystrophy-associated splicing defects

open access: yes
Angeli PD   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy